Abstract 931
Background
Colorectal cancer (CRC) history in first degree relative is a known risk factor for CRC and correlates with better survival in patients with early stage CRC. However, the prognostic effect of CRC history in first degree relatives (CHFR) in newly diagnosed synchronous metastatic CRC is not well known. The current study aims to determine prognostic roles of CHFR in patients with newly diagnose metastatic CRC.
Methods
A cohort of patients diagnosed with synchronous stage IV CRC during 2006-2010 in the province of Saskatchewan was studied. Patients who did not have information about family history (FH) were excluded. A Cox proportional multivariate analysis was performed to assess relationship between CHFR and survival.
Results
419 eligible patients with synchronous stage IV CRC were identified, 342 (81.6%) had a positive FH whereas 77 (18.4%) did not have a FH of cancer. Of 342 patients with a positive FH, 106 (30.9%) had a FH of CRC and 76 (22.2%) had CHFR (father, n = 21, mother, n = 15, brother, n = 20, sister, n = 15, son n = 3, daughter, n = 2). Of 76 patients with CHFR, 69 had one, 6 had 2, and one had 3 first degree relative with the diagnosis of CRC. Thirteen (12%) of 106 patients also had a diagnosis of CRC in a grandparent. Median overall survival of patients with CHFR who received chemotherapy was 17 months (95% CI: 13.9-20.1) compared with 22 months (19.1-24.9) if they don't have CHFR (p = 0.10). The Cox proportional multivariate model revealed following relationship between various variables and survival. Use of chemotherapy, HR: 0.30 (0.22-0.39), metastasectomy, HR: 0.41 (95% CI: 0.29-0.57), age
Conclusions
Unlike early stage CRC, CHFR does not correlate with better survival in patients with newly diagnosed synchronous stage IV CRC. In fact, we noted a trend toward inferior survival in patients with CHFR.
Clinical trial identification
Legal entity responsible for the study
N/A
Funding
Saskatchewan Cancer Agency
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
ZUMA-3: A phase 1/2 multi-center study evaluation the safety and efficacy of KTE-C19 anti-CD19 CAR T cells in adult patients with relapsed/refractory B precursor acute lymphoblastic leukemia (R/R ALL)
Presenter: Bijal Shah
Session: Poster display
Resources:
Abstract
ZUMA-2: A phase 2 multi-center study evaluating the efficacy of KTE-C19 (Anti-CD19 CAR T cells) in patients with relapsed/refractory Mantle cell lymphoma (R/R MCL)
Presenter: Michael Wang
Session: Poster Display
Resources:
Abstract
ZUMA-1: A phase 2 multi-center study evaluating anti-CD19 chimeric antigen receptor (CAR) T cells in patients with refractory aggressive non-Hodgkin lymphoma (NHL)
Presenter: Sattva Neelapu
Session: Poster Display
Resources:
Abstract
Younger age as a prognostic indicator in breast cancer: Correlation between clinical-pathologic factors and miRNAs and long-term follow-up
Presenter: Maria Teresa Martinez
Session: Poster display
Resources:
Abstract
Window study of the PARP inhibitor rucaparib in patients with primary triple negative or BRCA1/2 related breast cancer (RIO)
Presenter: Christy Toms
Session: Poster display
Resources:
Abstract
Whole exome sequencing (WES) and RNA sequencing (RNA-seq) in routine clinical practice for colorectal cancer (CRC) and non-small cell lung cancer (NSCLC) patients (pts)
Presenter: Géraldine Perkins
Session: Poster display
Resources:
Abstract
What is the optimal annual interpretive volume for a radiologist reading screening mammograms?
Presenter: Asli Uluturk
Session: Poster display
Resources:
Abstract
What decides breast conservation versus mastectomy in the background of diverse sociocultural environment, an Indian study
Presenter: Poonamalle Padmanabhan Bapsy
Session: Poster display
Resources:
Abstract
Waiting time to diagnosis and treatment of the head and neck cancer in four institutions in Portugal
Presenter: Ana Castro
Session: Poster display
Resources:
Abstract
Wait times for diagnosis and treatment of lung cancer: a single centre experience
Presenter: Catherine Labbe
Session: Poster Display
Resources:
Abstract